Bioxytran, Inc.

10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Unregistered sale of equity; Other events Mar 20, 2026 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws Mar 13, 2026 8-K Other events Mar 2, 2026 8-K Entered a material agreement; Other events Feb 17, 2026 8-K Other events Feb 11, 2026 8-K Director or officer change Jan 5, 2026 8-K Director or officer change Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Apr 3, 2025 8-K/A Entered a material agreement; Regulation FD disclosure Apr 3, 2025 8-K Entered a material agreement; Other events Jan 22, 2025 8-K Previously issued financials not reliable Jan 13, 2025 10-K/A Fiscal year ended 2023-12-31 Jan 13, 2025 8-K Other events Jan 10, 2025 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Entered a material agreement; Regulation FD disclosure Oct 29, 2024 8-K Modified rights of security holders; Other events Aug 20, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Other events Jul 17, 2024 8-K Other events Jul 5, 2024 8-K Changed accountants May 9, 2024 10-Q/A Quarter ended 2024-03-31 Apr 22, 2024 10-Q Quarter ended 2024-03-31 Apr 19, 2024 8-K Modified rights of security holders; Director or officer change Apr 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Other events Aug 24, 2023 10-Q Quarter ended 2023-06-30 Jul 31, 2023 8-K Entered a material agreement; Other events Jun 12, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Changed accountants Mar 7, 2023 8-K Other events Feb 6, 2023 8-K Other events Dec 14, 2022 8-K Other events Dec 8, 2022 8-K Other events Nov 16, 2022